BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT AND DEBT SETTLEMENT
VANCOUVER, BC, Jan. 8, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA: 5LB, OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it intends to complete a non-brokered private placement (the "Private Placement") consisting of up to 53,333,333 units ("Units") at a price of $0.03 per Unit for total gross proceeds of CAD$1,600,000.
- VANCOUVER, BC, Jan. 8, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA: 5LB, OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it intends to complete a non-brokered private placement (the "Private Placement") consisting of up to 53,333,333 units ("Units") at a price of $0.03 per Unit for total gross proceeds of CAD$1,600,000.
- Each Warrant is exercisable for one additional Common Share at an exercise price of $0.05 for a period of 24 months.
- All securities issued pursuant to the Private Placement are subject to a statutory hold period of four months and one day from the date of issuance.
- Closing of the Debt Settlement is conditional upon a number of conditions, including finalizing all contractual documentation and receipt of all applicable regulatory approvals and the policies of the CSE.